RNU6-1261P

Across TCGA pan-cancer cohorts, RNU6-1261P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-1261P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-1261P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1261P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BLCA, STAD, and GBM are the cancer types where RNU6-1261P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.209	0.633	<.001	81	view →
STAD	DFS	Tertile	All	0.417	0.725	.005	36	view →
GBM	OS	Tertile	All	0.104	0.415	.024	18	view →
ESCA	DFS	Tertile	III,IV	1.000	0.281	.043	12	view →
HNSC	DFS	Tertile	All	0.444	0.714	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-1261P–BLCA (DFS)

Open the BLCA breakdown →